The FDA has granted LBL-024 orphan drug designation (ODD) for the treatment of neuroendocrine cancer. The agent has already ...

Discover a recent clinical trial that explored the efficacy of combining pembrolizumab, an anti-PD-1 immunotherapy, with ...

Canadian cancer researchers are part of global efforts to test targeted alpha therapy, a new form of treatment that some ...

Exelixis plans to meet with the FDA's oncologic drugs advisory committee in March to discuss the drug's potential new uses. The meeting will review the safety and effectiveness of the cancer drug ...

Paul Teal, an actor who appeared in 'One Tree Hill' and 'Descendants: The Rise of Red,' died Friday after a seven-month ...

The global neuroendocrine carcinoma treatment market is poised for substantial growth, with revenue expected to reach USD ...

The world is lucky to have even had a moment with Paul Teal," his partner wrote in a tribute to the late actor.

From the deaths of actor Paul Teal and Chicago Bulls player Bob Love to a contestant on “Jeopardy!” revealing his colon ...

Leads Biolabs receives US FDA orphan drug designation for anti-PD-L1/4-1BB bispecific antibody, LBL-024 for treatment of neuroendocrine cancer: Nanjing, China Saturday, November 2 ...